| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.48 | 0.003 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |